vanoxerine has been researched along with Delayed Effects, Prenatal Exposure in 2 studies
vanoxerine: structure given in first source
vanoxerine : An N-alkylpiperazine that consists of piperazine bearing 2-bis(4-fluorophenyl)methoxy]ethyl and 3-phenylpropyl groups at positions 1 and 4 respectively. Potent, competitive inhibitor of dopamine uptake (Ki = 1 nM for inhibition of striatal dopamine uptake). Has > 100-fold lower affinity for the noradrenalin and 5-HT uptake carriers. Also a potent sigma ligand (IC50 = 48 nM). Centrally active following systemic administration.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Choong, KC | 1 |
| Shen, RY | 1 |
| Zachor, DA | 1 |
| Moore, JF | 1 |
| Brezausek, C | 1 |
| Theibert, A | 1 |
| Percy, AK | 1 |
2 other studies available for vanoxerine and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
Methylphenidate restores ventral tegmental area dopamine neuron activity in prenatal ethanol-exposed rats by augmenting dopamine neurotransmission.
Topics: Amphetamine; Animals; Dopamine; Dopamine Agents; Dopamine Uptake Inhibitors; Drug Interactions; Elec | 2004 |
Cocaine inhibits NGF-induced PC12 cells differentiation through D(1)-type dopamine receptors.
Topics: Animals; Brain; Carrier Proteins; Cell Differentiation; Cocaine; Dopamine; Dopamine D2 Receptor Anta | 2000 |